BooksTestimonialsInterviewsLibraryArticlesShop Here 


Scientific Studies

Hepatitis C Virus Causes Brain Inflammation Leading to Neuron Injury

Hepatitis C virus (HCV) can breach the blood-brain barrier and infect support cells in the brain, triggering inflammatory changes that ultimately result in damage to neurons, suggests new research published in the open access online journal PLoS One.

Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis

Shunichi Matsuoka, Hiroshi Matsumura, Hitomi Nakamura, Shu Oshiro, Yasuo Arakawa, Junpei Hayashi, Naoki Sekine, Kazushige Nirei, Hiroaki Yamagami, Masahiro Ogawa, Noriko Nakajima, Shuichi Amaki, Naohide Tanaka, and Mitsuhiko Moriyama*
Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, oyaguchi kamimachi, Itabashiku, Tokyo 173-8610, Japan
*To whom correspondence should be addressed.

FTC Imposes a New Standard for Competent and Reliable Scientific Evidence

This was forwarded to us regarding another companies dealings with FTC / FDA regulations on free speech.

Client Alert

A few months ago, we notified you that the Federal Trade Commission (“FTC” or “Commission”) intended to change its standard for “competent and reliable scientific evidence” as it applies to claims for over-the-counter (“OTC”) drugs, dietary supplements and functional foods, starting by imposing the new standard on individual companies through consent decrees. Now, as predicted, the FTC has introduced that new standard into consent decrees with Iovate Health Sciences, Inc. (“Iovate”) and Nestle HealthCare Nutrition, Inc. (“Nestle”).

Specifically, yesterday’s FTC consent decree with Iovate Health Sciences imposed a provision under which Iovate is barred from representing that its products cause weight loss or rapid weight loss unless the claims are truthful and backed by “competent and reliable scientific evidence” in the form of:

1.    At least two adequate and well-controlled human clinical studies,
2.    of the product at issue or an essentially equivalent product
3.    conducted by different experts independently of each other,
4.    that conform to acceptable designs and protocols and whose results, when
considered in light of the entire body of relevant and reliable scientific evidence, are sufficient to substantiate the claim.

Study evaluates effect of Viusid on oxidative stress, cytokine parameters in patients with CHC

The pathogenesis of chronic hepatitis C (CHC) is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect.

Study Shows Possible Benefit of <[censored]> Extract for Hepatitis C Virus

Recent research, funded in part by NCCAM and published in the journal Gastroenterology, has shown that an extract of the milk thistle plant may help treat hepatitis C virus infection. Hepatitis C, a liver disease caused by a virus, is usually chronic (long-lasting), with symptoms ranging from mild (or even none) to severe.

Top 5 Health Tips for Women

The National Heartburn Alliance tells us that more than 25 million Americans experience heartburn on a daily basis, and for the majority of them, acid-blocking drugs called proton pump inhibitors (PPIs) are the answer.

But thanks to an analysis of several recent studies, mainstream medicine may be on the verge of realizing what natural health practitioners have been saying for years—that prolonged use of PPIs comes with a laundry list of side effects that can take a serious toll on your health.

Largest study to date links chocolate to lower BP and CV risk

March 31, 2010 | Lisa Nainggolan

Nuthetal, Germany - The largest observational study so far to examine the association between chocolate consumption and risk of cardiovascular disease has found that those who ate the most chocolate—around 7.5 g per day—had a 39% lower risk of MI and stroke than individuals who ate almost no chocolate (1.7 g per day) [1].

Lead author Dr Brian Buijsse (German Institute of Human Nutrition, Nuthetal, Germany) told heartwire: "This shows that habitual consumption of chocolate is related to a lower risk of heart disease and stroke that is partly explained by blood-pressure reduction. The risk reduction is stronger for stroke than for MI, which is logical because it appears that chocolate and cocoa have a pronounced effect on BP, and BP is a higher risk factor for stroke than for MI." Buijsse and colleagues report their findings online March 31, 2010 in the European Heart Journal.

Syndicate content